Sirnaomics Ltd. is an international biopharmaceutical company that engages in developing and commercializing of RNAi technology and multiple therapeutics. Its lead clinical drug candidates include STP705 and STP707. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead. The company was founded by Yang Lu in 2007 and is headquartered in Hong Kong.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
69
Frequently Asked Questions
What is Market Cap of Sirnaomics Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sirnaomics Ltd. market cap is $1.35B.